Singapore, Aug. 1 -- Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfresa Holdings Corporation. Alfresa will partner with Ember to improve the quality of pharmaceutical cold chain logistics across Japan, including evaluating the Ember Cube and related technologies for Alfresa's Home Care Delivery service, which delivers specialty pharmaceuticals directly from medical institutions to patients' homes.

As part of the new alliance, Alfresa will provide financial support for Ember's business expansion through an investment in Series A preferred stock issued by Ember, strengthening collaboration between the two companies. Other investors in the Ember Series A include Amgen,...